Search - tctmd.com

Displaying 621 - 640 of 1056

Sort: Relevancy | Date

News Daily News

DES Linked With Lower In-Hospital Mortality Than BMS for All PCI Indications

Todd Neale

October 03, 2014

News Conference News TCT 2014

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Yael L. Maxwell

September 19, 2014

News Conference News TCT 2014

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

September 19, 2014

Presentation TCT 2014

Differences Between Polymeric and Metallic Bioresorbable Scaffolds

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Ron Waksman

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Yoshinobu Onuma

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: Biomechanics and Vascular Responses

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Juan F. Granada

September 16, 2014

Presentation TCT 2014

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Stephen G. Ellis

September 16, 2014

Presentation TCT 2014

EVERBIO II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting and Biolimus-Eluting Metallic Stents in Patients with Coronary Artery Disease

Presenter: Mitchell W. Krucoff, Giulio G. Stefanini, Stephane Cook

September 16, 2014

Presentation TCT 2014

Comparison of sirolimus-eluting stents with biodegradable polymer versus zotarolimus-eluting stents with durable polymer assessed by optical coherence tomography: The ALSTER-OCT___

Presenter: Christian Heeger

September 16, 2014

Presentation TCT 2014

2-Year Clinical Outcome of the Randomized, Multicenter DUTCH PEERS (TWENTE II) Trial, Comparing Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Stents and Platinum-Chromi___

Presenter: Clemens von Birgelen

September 16, 2014

Presentation TCT 2014

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Presenter: James Min

September 16, 2014

Presentation TCT 2014

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi, Lisette Okkels Jensen

September 14, 2014

Presentation TCT 2014

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Presenter: Gregg W. Stone, Pieter C. Smits, Fernando Alfonso

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

Presentation TCT 2014

Bare Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

Presenter: Emmanouil S. Brilakis, J. Dawn Abbott

September 13, 2014

News Conference News TCT 2014

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

September 13, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Conference News TCT 2014

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

September 13, 2014

News Conference News ESC 2014

PROTECT: ZES Sustain Lead Over SES at 5 Years

Caitlin E. Cox

September 03, 2014

News Daily News

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

L.A. McKeown

September 02, 2014

Advertisement

DES Linked With Lower In-Hospital Mortality Than BMS for All PCI Indications

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

Differences Between Polymeric and Metallic Bioresorbable Scaffolds

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Scaffolds vs Stents: Biomechanics and Vascular Responses

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

EVERBIO II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting and Biolimus-Eluting Metallic Stents in Patients with Coronary Artery Disease

Comparison of sirolimus-eluting stents with biodegradable polymer versus zotarolimus-eluting stents with durable polymer assessed by optical coherence tomography: The ALSTER-OCT___

2-Year Clinical Outcome of the Randomized, Multicenter DUTCH PEERS (TWENTE II) Trial, Comparing Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Stents and Platinum-Chromi___

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Bare Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

COMPARE II: BES, EES Show Similar Outcomes at Three Years

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

PROTECT: ZES Sustain Lead Over SES at 5 Years

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content